U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550751) titled 'Optimal Dosage of Melatonin for Preoperative Sedation in FESS' on April 11.
Brief Summary: To determine the optimal dosage of Melatonin for preoperative sedation in patients undergoing FESS.
Study Start Date: Aug. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Clinical Trial
Intervention:
DRUG: Melatonin
comparison between placebo and different melatonin doses(3-5-10 mg)
Recruitment Status: COMPLETED
Sponsor: Aswan University Hospital
Information provided by (Responsible Party): Osaid Abdelshakour Elsayed Abdallah, Aswan University Hospital
Published by HT Digital Content Services with permission from Health Daily Digest...